1FZD
STRUCTURE OF RECOMBINANT ALPHAEC DOMAIN FROM HUMAN FIBRINOGEN-420
Experimental procedure
Source type | SYNCHROTRON |
Source details | NSLS BEAMLINE X12C |
Synchrotron site | NSLS |
Beamline | X12C |
Temperature [K] | 293 |
Detector technology | CCD |
Collection date | 1998-02-20 |
Spacegroup name | P 1 |
Unit cell lengths | 71.250, 105.180, 71.140 |
Unit cell angles | 104.60, 108.95, 71.47 |
Refinement procedure
Resolution | 20.000 - 2.100 |
R-factor | 0.199 |
Rwork | 0.195 |
R-free | 0.25500 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1FCZ (GAMMA DOMAIN) |
RMSD bond length | 0.013 |
RMSD bond angle | 3.000 |
Data scaling software | SCALEPACK |
Phasing software | X-PLOR |
Refinement software | REFMAC |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 20.000 |
High resolution limit [Å] | 2.100 |
Rmerge | 0.098 |
Total number of observations | 1169328 * |
Number of reflections | 110459 |
Completeness [%] | 91.2 |
Redundancy | 5.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 * | PROTEIN WAS CRYSTALLIZED BY SITTING DROP VAPOUR DIFFUSION FROM 20% PEG 3350, 0.15 M CACL2, 0.1M IMIDAZOLE- ACETATE PH 5.5 0.002 M SODIUM AZIDE, vapor diffusion - sitting drop |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | reservoir | PEG3350 | 20 (%) | |
2 | 1 | reservoir | 0.15 (M) | ||
3 | 1 | reservoir | imidazole acetate | 0.1 (M) | |
4 | 1 | reservoir | sodium azide | 0.002 (M) | |
5 | 1 | drop | protain | 8 (mg/ml) | |
6 | 1 | drop | Tris | 0.02 (M) |